Categories: News

Inside the AI-Powered Enterprise: New Whitepaper Reveals How Gen AI is Redefining ROI

MUMBAI, India, July 11, 2025 /PRNewswire/ — Practus, a leading ROI-driven business consulting firm, and Pathsetter AI, a next-gen AI transformation company, have jointly released a groundbreaking whitepaper titled ‘The Future of Enterprise Intelligence: Integrating GenAI for Competitive Advantage’. This timely research provides a strategic roadmap for how enterprises can harness Generative AI (Gen AI) to transform decision-making, boost performance, and create measurable business value.

- Advertisement -

With decision cycles shrinking and data values exploding, traditional Business Intelligence (BI) systems are no longer sufficient. The whitepaper explores how Gen AI, embedded within a broader Enterprise Intelligence (EI) framework, enables real-time, predictive, and outcome-driven decision-making across key business functions—from finance and operations to customer experience and compliance.

- Advertisement -

“Enterprise Intelligence is about turning insight into action, faster, smarter and with tangible impact,” said Deepak Narayanan, Founder & CEO of Practus. “Gen AI isn’t just about automating reports. It’s about engineering better decisions at scale. As this paper shows, the winners in this new era will be those who shift from dashboards to direction—from pilots to performance. At Practus, we see Gen AI as a strategic enabler of ROI, not a science experiment.”

- Advertisement -

The whitepaper combines market insights, real-world case studies, and a practical Gen AI maturity model. Highlights include:

- Advertisement -
  • 67% reduction in manual customer support interventions
  • Up to 30% faster content production time
  • 15-25% improvement in customer satisfaction scores
  • Forecast accuracy exceeding 90% using AI-powered models

The whitepaper also introduces a shift toward ‘Outcomes as a Service’ (OaaS) – a new model where Gen AI solutions are tied to measurable business KPIs like cost savings, margin improvements, and faster time-to-insight. It serves as both a blueprint and a call to action for enterprises ready to move from experimentation to execution.

- Advertisement -

Whitepaper Linkhttps://roibypractus.com/2025/06/25/the-future-of-enterprise-intelligence-integrating-gen-ai-for-competitive-advantage/

- Advertisement -

About Practus:

- Advertisement -

Practus redefines the consulting landscape by delivering measurable ROI across finance, operations, strategy, and people transformation. With operations in 10 countries and a cumulative client impact of over $500 million, Practus is committed to results—not just recommendations.

- Advertisement -

Website: www.roibypractus.com

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/inside-the-ai-powered-enterprise-new-whitepaper-reveals-how-gen-ai-is-redefining-roi-302503134.html

- Advertisement -
PRNW Agency

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

5 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

1 week ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago